New class of anti-influenza macromolecules based on beta-cyclodextrin
A new class of anti-influenza macromolecules were synthesized based on a cyclodextrin to target conserved viral domains irreversibly. 6’ sialyl-N-acetyllactosamine
Tag: CDs are APIs
CTD Announces Partnership with United BioSource
CTD Holdings, a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need,